Retraction
Asiaticoside inhibits renal fibrosis development by regulating the miR-142-5p/ACTN4 axis
Paper Information
Record ID:
40587
Author(s):
Journal:
Publication Date:
February 25, 2021
Retraction Date:
November 14, 2022
(3.0 years years ago)
Subjects:
Institutions:
- Department of Nephropathy, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210000 People's Republic of China
- Department of Nephropathy, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, No.23 Nanhu Road, Jianye District, Nanjing, Jiangsu, 210000 People's Republic of China
- Pharmacy Dispensary, Affiliated Hospital of Jining Medical University, Jining, Shandong, People's Republic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (9)
9
Total Citations6
Post-Retraction(66.7%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
2
After 2+ years
791
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Prognostic assessment of early-stage liver cirrhosis induced by HCV using an integrated model of CX3CR1-associated immune infiltration genes
Haozheng Cai, Jing Zhang, Chuwen Chen et al. (9 authors)
Scientific Reports
Open Access
Published: Jan 2025
1 citation
1 citation
791 days after retraction
Asiaticoside reverses the inhibition effect of miR-184 on proliferation, migration and AKT phosphorylation of HTR-8/Svneo cells
Zhifan Jia, Yumei Long, Xiangyue Li et al. (7 authors)
Turkish Journal of Biochemistry
Open Access
Published: Dec 2024
777 days after retraction
Assessing prognosis in HCV-induced early-stage liver cirrhosis: An integrated model based on CX3CR1-associated immune infiltration genes
Haozheng Cai, Jing Zhang, Chuwen Chen et al. (9 authors)
Research Square (Research Square)
Open Access
Published: May 2024
541 days after retraction
Asiaticoside ameliorates renal ischemia/reperfusion injury by promoting CD4+CD25+FOXP3+ treg cell differentiation
Shengjie Tang, Xiangcheng Xie, Ming Wang et al. (4 authors)
Heliyon
Open Access
Published: Jun 2023
4 citations
4 citations
223 days after retraction
Retraction: MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways
Unknown Authors
Pathology & Oncology Research
Open Access
Published: May 2023
192 days after retraction
Therapeutic properties and pharmacological activities of asiaticoside and madecassoside: A review
Shinjini Bandopadhyay, Sujata Mandal, Mimosa Ghorai et al. (10 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Feb 2023
98 citations
98 citations
86 days after retraction
A review of pharmacokinetic and pharmacological properties of asiaticoside, a major active constituent of Centella asiatica (L.) Urb.
Ziliang He, Yeye Hu, Zhiqiang Niu et al. (8 authors)
Journal of Ethnopharmacology
Published: Oct 2022
59 citations
59 citations
19 days before retraction
Asiaticoside conveys an antifibrotic effect by inhibiting activation of hepatic stellate cells via the Jagged-1/Notch-1 pathway
Xianhong Xiao, Qiang Zhang
Journal of Natural Medicines
Published: Sep 2022
3 citations
3 citations
47 days before retraction
Quick Stats
Total Citations:
16
Years Since Retraction:
3.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025